LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 38 filers reported holding LYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222,905 | +82.5% | 57,009 | +91.9% | 0.00% | – |
| Q2 2023 | $122,120 | +103.7% | 29,713 | -0.4% | 0.00% | – |
| Q1 2023 | $59,956 | -36.0% | 29,829 | 0.0% | 0.00% | – |
| Q4 2022 | $93,663 | -37.1% | 29,829 | 0.0% | 0.00% | – |
| Q3 2022 | $149,000 | -11.8% | 29,829 | 0.0% | 0.00% | – |
| Q2 2022 | $169,000 | -77.3% | 29,829 | -53.7% | 0.00% | – |
| Q1 2021 | $746,000 | -3.7% | 64,451 | -5.2% | 0.00% | – |
| Q4 2020 | $775,000 | +41.7% | 67,995 | +39.1% | 0.00% | – |
| Q3 2020 | $547,000 | -6.8% | 48,887 | -5.7% | 0.00% | – |
| Q2 2020 | $587,000 | – | 51,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,777,251 | $5,580,568 | 1.20% |
| Perceptive Advisors | 9,146,730 | $28,720,732 | 0.81% |
| VR Adviser, LLC | 924,170 | $2,901,894 | 0.49% |
| Nantahala Capital Management | 2,220,830 | $6,973,406 | 0.45% |
| PURA VIDA INVESTMENTS, LLC | 2,157,298 | $6,773,916 | 0.35% |
| Soleus Capital Management, L.P. | 592,417 | $1,860,189 | 0.27% |
| Ikarian Capital, LLC | 343,685 | $1,079,171 | 0.26% |
| Clearline Capital LP | 119,128 | $374,062 | 0.07% |
| Anson Funds Management LP | 39,127 | $122,859 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 146,800 | $460,952 | 0.01% |